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Abstract
Background: Along with high affinity binding of epibatidine (Kd1≈10 pM) to a4b2 nicotinic acetylcholine receptor
(nAChR), low affinity binding of epibatidine (Kd2≈1-10 nM) to an independent binding site has been reported.
Studying this low affinity binding is important because it might contribute understanding about the structure and
synthesis of a4b2 nAChR. The binding behavior of epibatidine and a4b2 AChR raises a question about interpreting
binding data from two independent sites with ligand depletion and nonspecific binding, both of which can affect
equilibrium binding of [
3H]epibatidine and a4b2 nAChR. If modeled incorrectly, ligand depletion and nonspecific
binding lead to inaccurate estimates of binding constants. Fitting total equilibrium binding as a function of total
ligand accurately characterizes a single site with ligand depletion and nonspecific binding. The goal of this study
was to determine whether this approach is sufficient with two independent high and low affinity sites.
Results: Computer simulations of binding revealed complexities beyond fitting total binding for characterizing the
second, low affinity site of a4b2 nAChR. First, distinguishing low-affinity specific binding from nonspecific binding
was a potential problem with saturation data. Varying the maximum concentration of [
3H]epibatidine,
simultaneously fitting independently measured nonspecific binding, and varying a4b2 nAChR concentration were
effective remedies. Second, ligand depletion helped identify the low affinity site when nonspecific binding was
significant in saturation or competition data, contrary to a common belief that ligand depletion always is
detrimental. Third, measuring nonspecific binding without a4b2 nAChR distinguished better between nonspecific
binding and low-affinity specific binding under some circumstances of competitive binding than did presuming
nonspecific binding to be residual [
3H]epibatidine binding after adding a large concentration of cold competitor.
Fourth, nonspecific binding of a heterologous competitor changed estimates of high and low inhibition constants
but did not change the ratio of those estimates.
Conclusions: Investigating the low affinity site of a4b2 nAChR with equilibrium binding when ligand depletion
and nonspecific binding are present likely needs special attention to experimental design and data interpretation
beyond fitting total binding data. Manipulation of maximum ligand and receptor concentrations and intentionally
increasing ligand depletion are potentially helpful approaches.
Background
Ligand depletion can significantly affect estimates for dis-
sociation (Kd) or inhibition (Ki) constants from equili-
brium binding data of epibatidine (EB) and a4b2 nicotinic
acetylcholine receptor (nAChR) because of the high affi-
nity of EB (Kd1≈10 pM). Errors from ligand depletion arise
from inappropriately assuming that free ligand concentra-
tion equals total ligand concentration while using total
ligand concentration as the independent variable for mod-
eling the binding data. The assumption is attractive
because total ligand concentration as the independent
variable is suitable for least squares fitting of binding data
[1,2]. Ligand depletion can be minimized when designing
binding experiments with EB and a4b2 nAChR. Radiola-
beled EB with higher specific activity (for example,
125I
instead of
3H) can lead to less ligand depletion by allowing
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data. A larger reaction volume at a fixed mole quantity of
a4b2 nAChR reduces ligand depletion by reducing the dif-
ference between free and total concentration of radiola-
beled EB. These avoidance strategies based on design of
experiments, however, might be difficult to use in some
situations. For example, a newly developed and
3H-labeled
EB derivative might be available only with low specific
activity. Large reaction volumes might be impractical for
numerous samples associated with high throughput
screening [3]. When ligand depletion cannot easily be
avoided, how can data with both ligand depletion and
nonspecific binding (NSB) be correctly interpreted from
EB and a4b2 nAChR?
Effects of ligand depletion on binding data have long
been recognized, leading to models that correctly include
ligand depletion with single and multiple specific binding
sites [3-9]. For [
3H]EB, a ligand with relatively low speci-
fic activity, and a4b2 nAChR, ligand depletion has been
recognized and avoided as a potentially confounding fac-
tor for interpreting binding data [10-17]. Alternatively,
one site and two sites models for estimating binding con-
stants have included ligand depletion with negligible NSB
[18]. Combining ligand depletion and NSB, however,
imposes additional demands on binding models. For
example, specific binding cannot be calculated simply by
subtracting NSB from total binding. Instead, a binding
model including both ligand depletion and NSB must fit
total binding [6] as has been shown with one specific
binding site [19]. In addition to the high potency or high
affinity site, functional data from electrophysiology and
86Rb
+ flux [20-41] and binding data [12,18,20,42,43] for
a4b2o ra4b2-containing nAChR suggest a second, low
potency or low affinity specific binding site. The differ-
ence in agonist potency at the two sites in functional
assays has been attributed to a4b2 nAChR with different
a:b stoichiometries [21,25,28,30,33]. (a4)2(b2)3 contri-
butes high potency and (a4)3(b2)2 contributes low
potency. Binding data from our laboratory suggest two
independent sites and not two cooperative sites [18]. The
physical basis of low affinity equilibrium binding of [
3H]
EB detected under some conditions and the relationship
between the low affinity site observed by equilibrium
binding and the low potency site observed by functional
methods are not known. On the other hand, a single
binding site has been suggested for a4b2 nAChR [12,14]
and for extracellular domain a4b2n A C h R[ 1 8 ]f r o m
binding data. Photolabeling of a4b2w i t h[
3H]EB also
identified a single binding site [44]. Models of a4b2
nAChR binding data, therefore, should not assume the
presence of high and low affinity sites. Instead, an inter-
pretation of binding data needs to test the hypothesis of
one binding site versus more than one binding site.
How does interpreting binding data with ligand deple-
tion with NSB and a single binding site [19,45] need to be
modified when a second, low-affinity specific binding site
might be present from a4b2 nAChR? Detecting and accu-
rately interpreting properties of the low affinity site is
important because of the potential biological relevance of
the low-affinity specific site. The low affinity binding site
might reflect biologically important roles for a4b2
nAChR, reflect a variant structure of the agonist binding
site, or give insight into the assembly of a4b2 nAChR. The
goal of this study was to determine, using computational
modeling, whether fitting total binding is sufficient for
characterizing the low affinity binding site from a4b2
nAChR in the context of ligand depletion and NSB. The
modeling simulated saturation binding, homologous com-
petition, and heterologous competition. The experimental
foundation for the modeling was reported previously with
Kd1 = 13 pM for the high affinity site and Kd2 =1 2n Mf o r
the low affinity site [18]. The findings are potentially rele-
vant to other ligands and receptors when two or more spe-
cific binding sites are possible and when ligand depletion
and NSB affect binding data.
Methods
Equations of the models
For an introduction to interpreting equilibrium binding
with ligand depletion and NSB, see Swillens [19] and
Motulsky and Christopoulos [7]. The models of saturation
binding and homologous and heterologous competition
were based on mass action equations and conservation of
mass (Figure 1). Figure 1 shows the notations for the states
and equations for the equilibrium dissociation and inhibi-
tion constants of the models. Equations for a model were
solved numerically within a Microsoft Excel environment
using the Maple version 13 or 14 (Maplesoft) add-in. Para-
meters of a model were optimized to simulated data with
the method of least squares using Excel and the Premium
Solver Platform (Frontline Systems). Values of parameters
were constrained to physically valid values.
Analytical solutions of cubic equations are available that
describe ligand depletion (with and without NSB) of two
binding sites and one ligand or of two sites with homolo-
gous competition [3,9,18,46,47]. Analytical solutions of a
quartic polynomial describing ligand depletion and NSB of
three binding sites and one ligand or of two binding sites
with homologous competition can be derived from the
general solution of a quartic polynomial [48]. Numerical
solutions were used in this investigation because of the
relative ease of implementation and the usefulness of
numerical solutions when roots of quintic and higher
order polynomials are needed to describe ligand depletion
but for which analytical solutions are not available. For
example, roots of a sixth order polynomial are needed to
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ligand depletion and NSB, which precludes an analytical
solution.
Data generation and model fitting
True binding behaviors (i.e., noiseless data) were defined
as the output from two-sites models using defined
values of parameters and free ligand concentration as
the independent variable (two sites modelfree). Noise was
superimposed by adding, to each noise-free data point, a
random number selected from a standard normal distri-
bution with a constant standard deviation (SD) deter-
mined by context. The SD value was constant along the
x-axis. In some cases, noise was described by the maxi-
m u ms i g n a lt on o i s er a t i o( S / N ) .T h eS Df o rn o i s ew a s
the maximum signal in the noiseless data divided by the
m a x i m u ms i g n a lt on o i s er a t i o( i . e . ,S D=( m a x i m u m
signal)/(stated maximum S/N)). Multiple data sets with
different SD values for noise were fitted simultaneously
by weighting, by the inverse of the variance of the noise,
the contribution of a data set to the sum of squares.
Total concentration of added ligand was the indepen-
dent variable for the one site modeltotal and two sites
modeltotal when fitting noiseless and noisy data that
included NSB. All results are displayed using total con-
centration on the x-axis. All ligand concentrations
appearing in the text refer to total concentration unless
otherwise noted. The two sites model for saturation
binding that ignored ligand depletion assumed that LT
= L. The two sites model of apparent specific saturation
binding was based on equations (c)-(g) and assumed a
= 0 in equation (g) (Figure 1). Apparent specific binding
was the difference between total binding and apparent
NSB. Apparent NSB was defined as NSB measured inde-
pendently without a4b2 nAChR and equaled a/(1+a)*
(total [
3H]EB). The Hill equation (Eq. (1)) for character-
izing binding data by fitting with SigmaPlot 11 was:
y = A0/

1+( K0.5/x)
n
(1)
Data were generated with the following parameter
values published by our laboratory [18] unless otherwise
stated: Kd1 =0 . 0 1 3n Ma n dKd2 =1 2n Mf o r[
3H]EB;
Ki1 =0 . 8 4a n dKi2 = 775 nM for nicotine; fraction of
R1T = 0.84; fraction of R2T = 0.16 (see Figure 1 for
notation). When a R1T concentration is stated, the cor-
responding R2T concentration is implied.
Statistics
The one site models for saturation binding and competi-
tion data were simpler cases of the two sites models,
making these two types of models nested [7]. Qualities
of fit of the two types of models, therefore, were com-
pared with the F-test [49]. The level of significance for
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Figure 1 Equations for the binding models are based on the
law of mass action and conservation of mass. Two mass action
equations (c)-(d) for dissociation constants derived from (a)-(b) and
three conservation of mass equations (e)-(g) formed the five
equations solved simultaneously for the two sites modeltotal for
saturation binding. Four mass action equations for dissociation
constants derived from (i)-(l) and four conservation of mass
equations (m)-(p) formed the eight equations solved simultaneously
for the two sites modeltotal for homologous or heterologous
competition. L was the independent variable for two sites modelfree
for saturation binding, which did not include Eq. (g). B was the
independent variable of two sites modelfree for competition, which
did not include Eq. (p). One site modeltotal excluded terms referring
to the second site. The two sites model for saturation binding that
ignored ligand depletion was based on Eqs. (c)-(f) and assumed LT
= L. Notation: aL = constant describing NSB of radioligand; Kd1 =
dissociation constant of high affinity binding site; L = free
radioligand; LT = total radioligand; NSBL = nonspecific binding of
radioligand; R1 = unbound first binding site; R1L = radioligand
bound to first site; R1T = total high affinity binding site; B = free
competitor (blocker). With analogous notations, the index “2” in
these equations refers to the low affinity binding site.
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confidence interval (CI) was 95%. CIs for dissociation
constants and average p values were based on logarith-
mic values.
Results
Effects of ligand depletion and NSB on saturation binding
to two specific sites
The two sites modelfree generated errorless binding data
using free [
3H]EB as the independent variable to investi-
gate how ligand depletion without NSB affected satura-
tion binding behavior. Increasing the concentration of
binding sites increased ligand depletion, shifted the total
binding curve to the right, increased the steepness of
the curve, and obscured the distinctive contour of the
low affinity binding site (Figure 2A). The binding con-
tour of the high affinity site began shifting noticeably to
the right and showed an increasingly sharp bend at [
3H]
EB = R1T as R1T increased beyond Kd1 (0.013 nM) (Fig-
ure 2B). The binding contour of the low affinity site
started shifting rightward as R1T approached Kd2 (12 nM).
The rightward shift in the binding curves with ligand
depletion means that relying on K0.5 as an estimate of Kd
overestimates dissociation constants. Eq. (2)
Kd1 =K 0.5,high − (R1T/2) (2)
correctly estimated Kd1 from the half-maximum for
the high affinity site (K0.5, high)w h e nK 0.5, high was dis-
tinct [5,50]. Eq. (2), however, became increasingly diffi-
cult to use as rightward shift of the binding curve from
the high affinity site led to overlap with the binding
curve from the low affinity site.
The two sites modelfree generated errorless binding data
with both ligand depletion and NSB to investigate how
combining NSB with ligand depletion affected binding
behavior. The effect of NSB depended on the extent of
ligand depletion. With negligible ligand depletion at R1T
= 0.0001 nM (Figure 3A), NSB with a =1 0
-6 started
obscuring the binding contour from the low affinity site.
NSB with a =1 0
-3 obscured binding to the high affinity
site. With significant ligand depletion at R1T = 0.3 nM
(Figure 3B), NSB with a =1 0
-4 obscured the binding con-
tour from the low affinity site. With extreme ligand deple-
tion at R1T = 300 nM (Figure 3C), the contributions to
total binding from the high affinity site and the low affinity
site were not distinct even without NSB. NSB with a =1
obscured specific binding to the high affinity site. Increas-
ing ligand depletion also affected how NSB depended on
total [
3H]EB concentration. The leftward shift in NSB with
each log unit increase in a was relatively uniform when
ligand depletion was negligible at R1T = 10
-4 nM (Figure
3D). The leftward shift in NSB with each log unit increase
in a, however, became nonuniform when ligand depletion
became large (Figure 3E; R1T = 0.3 nM) or extreme
(Figure 3F; R1T = 300 nM).
Modeling specific binding and NSB as total binding
How can dissociation constants be estimated when both
ligand depletion and NSB contribute significantly to [
3H]
EB binding? An effective approach when ligand depletion
is negligible is to calculate specific binding as the differ-
ence between total binding and NSB measured without
a4b2 nAChR (apparent NSB). In accord with a one bind-
ing site model including ligand depletion and NSB [19],
this approach was incorrect when ligand depletion was
significant (Figure 3G and 3H). NSB shifted rightward
from the apparent NSB as R1T increased because
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Figure 2 Ligand depletion shifts the binding curve rightward
and obscures distinct features of the two binding sites. A.
Fractional occupancy of total specific binding sites is shown at
various concentrations of R1T. Increasing total binding sites
increases ligand depletion, which shifts the total binding curve
rightward. Ligand depletion also distorts the two sigmoidal features
arising from binding to the high and low affinity sites. B. The
fractional occupancies of high and low affinity sites are shown
separately. The legend in A applies to B. Fractional occupancies of
the low affinity site are clustered in the lower right corner of the
plot. Only lines from R1T values of 13 and 130 nM are distinct for
the low affinity site. The leftmost line from the low affinity site arises
from overlap of the lines from the first five concentrations of
binding sites. Binding was calculated with two sites modelfree.
Person and Wells BMC Biophysics 2011, 4:19
http://www.biomedcentral.com/2046-1682/4/19
Page 4 of 220.0
5.0e-5
1.0e-4
1.5e-4
2.0e-4
α=0
R1T=
0.0001 nM
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
α=0.1
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.0
0.2
0.4
0.6
0.8
1.0
1.2
R1T=1
R1T=0.5
R1T=0.3
R1T=0.1
α=0.1
-6 -4 -2 0 2 4 6
0
100
200
300
400
500
R1T=
300 nM
0.0
0.1
0.2
0.3
0.4
0.5
-7
-5
-3
-1 R1T=0.3 nM
α=0
α (log)
0.0000
0.0005
0.0010
0.0015
0.0020
0.0000
0.0005
0.0010
0.0015
0.0020
-5 -3 -1 1 3 5
0.0000
0.0005
0.0010
0.0015
0.0020
-7
-5
-3
-1
RT1=
0.0001nM
RT1=
0.3 nM
RT1=
300 nM
α (log)
A.
B.
C.
D.
E.
F.
B
o
u
n
d
 
[
3
H
]
E
B
 
(
n
M
)
N
o
n
s
p
e
c
i
f
i
c
a
l
l
y
 
b
o
u
n
d
 
[
3
H
]
E
B
 
(
n
M
)
Log(total [3H]EB (nM))
B
o
u
n
d
 
[
3
H
]
E
B
 
(
n
M
)
Total [3H]EB (nM)
G. H.
Log(total [3H]EB (nM))
Total [3H]EB (nM)
N
S
B
 
[
3
H
]
E
B
 
(
n
M
)
Figure 3 NSB depends on the extent of ligand depletion and cannot be calculated from apparent NSB. A. Total binding is shown when
ligand depletion is negligible with increasing values of a ranging from 0 to 1 (integer log values of a from -7 to 0; legend for A-C in B). a =0
is line with horizontal plateau at large concentration of [
3H]EB. B and C. Similar to A except ligand depletion is substantial (R1T = 0.3 nM) or
extreme (R1T = 300 nM). The effects of a particular a value on total binding depend on the extent of ligand depletion. D, E, F. NSB on
expanded y-scales shows how increasing ligand depletion affects NSB (legend for a in F; integer log values from -7 to 0). G. Specific binding is
not calculated correctly as the difference between total binding and apparent NSB when ligand depletion is significant. Solid black line: apparent
NSB obtained without a4b2 nAChR. Lines for total binding at increasing concentrations (nM) of R1T and, therefore, increasing ligand depletion
appear above apparent NSB. Corresponding lines for NSB when a = 0.1 are below apparent NSB. H. NSB (same code for lines as in G) and
apparent NSB (solid line) from G are shown with an expanded y-scale. Binding in this figure was calculated with two sites modelfree.
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3H]EB concentration
for a given total concentration of [
3H]EB. Subtracting
apparent NSB from total binding led to calculated speci-
fic binding that was shifted rightward and downward
compared to true specific binding (Figure 4A). This effect
led to overestimating the values of Kd1 and Kd2 (Figure
4B and 4C), overestimating R1T (Figure 4D and 4E), and
underestimating R2T (Figure 4D and 4E) as ligand deple-
tion increased. The difference between total binding and
NSB equals specific binding by definition. These results,
however, showed NSB when a4b2n A C h Rw a sp r e s e n t
was not equal to NSB when a4b2n A C h Rw a sa b s e n t
(apparent NSB). Specific binding, therefore, did not equal
the result of subtracting apparent NSB from total bind-
ing. This inequality arose because NSB with a4b2
nAChR present did not equal apparent NSB when ligand
depletion was significant. This observation has been
made previously for a one site model [19].
Specific binding and NSB of [
3H]EB and a4b2 nAChR
needed to be modeled together as total binding using
the two sites modeltotal. This conclusion was consistent
with the findings from a general one site model [19].
Accuracy of the two sites modeltotal for calculating
saturation binding data was tested by comparing pre-
dicted [
3H]EB binding to [
3H]EB binding calculated with
two sites modelfree. The concentration of bound [
3H]EB
calculated by the two methods agreed to at least four-
teen significant digits across this range of parameters:
10
-6 nM ≤ R1T ≤ 10
4 nM and 0 ≤ a ≤ 10
2 with 10
-6
nM ≤ [
3H]EBfree ≤ 10
6 nM. These results confirmed the
accuracy of the binding calculations using the two sites
modeltotal.
Potential for failing to identify low-affinity specific
binding when modeling only total saturation binding
A ni m p o r t a n tr o l ef o rt h et w os i t e sm o d e l total is to
estimate dissociation constants and binding site con-
centrations from noisy binding data. These estimates,
however, are valid only when the two sites modeltotal
fits data better than does the one site modeltotal
according to statistical testing. Under what circum-
stances are binding data from the two sites of a4b2
nAChR adequately explained by the one site modeltotal?
In these situations, specific binding to the low affinity
site is indistinguishable from high-affinity specific
binding, NSB, or noise. On the other hand, what cir-
cumstances favor identifying the low-affinity specific
binding site?
Deriving a computational expression for NSB from
t h eg e n e r a le x p r e s s i o nf o rb i n d i n gt oas i n g l es i t es u g -
gested potential confusion between low-affinity specific
binding and NSB as defined in Figure 1 (symbols similar
to Figure 1):
Kd =

R
RL

∗ Lf (3)
RLNSB =

RNSB
Kd,NSB

∗ Lf =

RTNSB
Kd,NSB

∗ Lf (4)
RLNSB =N S B=α*Lf (5)
where a =( R T NSB/Kd, NSB)a n dR NSB =R T NSB by the
definition of homogeneous NSB. If NSB arises from a
collection of heterogeneous sites, then
RLNSB,total =

RNSB,1
Kd,NSB,1
+
RNSB,2
Kd,NSB,2
+ ···

∗ Lf (6)
RLNSB,total =

RTNSB,1
Kd,NSB,1
+
RTNSB,2
Kd,NSB,2
+ ···

∗ Lf (7)
RLNSB,total =N S B=α ∗ Lf (8)
By analogy with these derivations, binding to the low
affinity site also can be modeled as constant*Lf, similar
to NSB, when R2≃R2T. On the other hand, low-affinity
specific binding behaves differently from NSB when the
approximation R2≃R2T fails. This approximation most
likely fails as total [
3H]EB approaches its maximum con-
centration ([
3H]EBmax) in a saturation binding experi-
ment. In contrast and by definition, RNSB≃RTNSB is valid
for NSB; and NSB equals a*Lf at any [
3H]EBmax.W h e n
[
3H]EBmax is sufficiently small that R2≃R2T is valid for
the low-affinity specific binding site, the two sites mod-
eltotal does not fit significantly better than one sites
modeltotal. This outcome supports the incorrect conclu-
sion that a second low affinity site is not present. These
observations led to the hypothesis that modeling total
saturation binding data with ligand depletion and NSB
can blur the important biological distinction between
low-affinity specific binding and NSB for [
3H]EB and
a4b2 nAChR.
Three approaches to characterizing the low-affinity
specific binding site with saturation binding
To test this hypothesis, the one site modeltotal was com-
pared to the two sites modeltotal by fitting noisy total
binding data from the two sites modelfree with zero NSB
(a = 0). The data (60 data points and 20 total concentra-
tions of [
3H]EB) with R1T = 0.13 nM and [
3H]EBmax =2
nM were generated with the two sites modelfree and an
unrealistically large maximum signal-to-noise ratio (S/N)
of 13,300 (SD = 1 × 10
-5 nM). The two sites modeltotal
fitted the data significantly better than the one site mod-
eltotal (p values of 1.5 × 10
-24,2 . 2×1 0
-22,a n d1 . 3×1 0
-20
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Figure 4 Calculating specific binding by subtracting apparent NSB from total binding of [
3H]EB to a4b2 nAChR leads to errors in
estimating dissociation constants and binding site concentrations. A. Apparent specific binding (dashed lines) calculated by subtracting
apparent NSB (a = 0.1) from total binding is less than the true specific binding (solid lines). These errors in specific binding lead to errors in
estimating Kd1 and Kd2 (B and C) and R1T and R2T (D and E) from a two sites model that includes ligand depletion but excludes NSB. B and D
were obtained with a = 0.01; C and E were obtained with a = 0.1. The x-axis in B-E is an index of ligand depletion. Binding data shown or used
in this figure were calculated with two sites modelfree.
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Page 7 of 22for three trials). This result showed that fitting high pre-
cision total binding data with the two models identified
low-affinity specific binding.
Reducing the precision of the data was expected to
make detection of binding to the low affinity site more
difficult. To test this expectation, binding data with the
same R1T and [
3H]EBmax were generated with a tenfold
smaller but still unrealistically large maximum S/N of
1,330 (SD = 1 × 10
-4 nM). Under these conditions, the
two sites modeltotal did not fit the data significantly bet-
ter than the one site modeltotal with five of five data sets
(p = 0.33, 0.13, 0.24, 0.73, and 1.0). Fitting noisier data
led to the misleading conclusion that only one specific
binding site plus NSB satisfactorily accounted for the
total binding data.
How can low-affinity specific binding be distinguished
more reliably from NSB as S/N values decrease to realis-
tic levels? Eqs. (3)-(5) suggested increasing [
3H]EBmax so
the approximation R2≃R2T no longer would be valid
near [
3H]EBmax. The approximation would break down
because increased binding of [
3H]EB to R2 at large values
of [
3H]EB would cause a significant decrease in R2 as
[
3H]EB approaches the increased value of [
3H]EBmax.T o
determine whether increasing [
3H]EBmax helped distin-
guish the low affinity binding site from NSB in the pre-
s e n c eo fl i g a n dd e p l e t i o n ,t h eo n es i t em o d e l total and the
two sites modeltotal were fitted to noisy data with zero
NSB and with [
3H]EBmax increased from 2 nM (60 data
points) to 5 nM (63 data points). The maximum S/N of
t h ed a t aa g a i nw a s1 , 3 3 0( S D=1×1 0
-4 nM). With [
3H]
EBmax = 5 nM, the two sites modeltotal fit better than the
one site modeltotal in five of five data sets (p = 4.6 × 10
-11,
1.8 × 10
-9, 2.8 × 10
-9, 2.5 × 10
-9, and 1.7 × 10
-12). Increas-
ing the data points from 60 to 63 did not account for this
improved detection of low-affinity specific binding.
Instead, this result was consistent with a breakdown of
the approximation R2≃R2T as [
3H]EBmax increased, lead-
ing to better discernment of binding at the low affinity
site at [
3H]EBmax = 5 nM compared to 2 nM.
To explore whether larger values of [
3H]EBmax could
distinguish low-affinity specific binding from NSB in data
with more realistic precision, the one site modeltotal and
two sites modeltotal were fitted to noisy data (maximum S/
N = 36; SD = 0.0041 nM) and zero NSB (a =0 )( F i g u r e
5A). When [
3H]EBmax was 10 nM, the two sites modeltotal
usually did not fit the data better than the one site model-
total.A s[
3H]EBmax increased, the likelihood of better fitting
by the two sites modeltotal and the likelihood of support
for the presence of the low affinity site also increased. At
[
3H]EBmax = 100 nM with fitting total binding data only,
the two sites modeltotal fitted the data better than the one
site modeltotal for all trials. The increase in data points
with increasing [
3H]EBmax did not account for this
improved detection of low-affinity specific binding.
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Figure 5 Increasing [
3H]EBmax or simultaneously fitting
apparent NSB helps identify low-affinity specific binding. A.
Data sets with maximum S/N = 36 (SD = 0.0041 nM), R1T = 0.13
nM, a = 0, and various values of [
3H]EBmax were fitted with one site
modeltotal and two sites modeltotal. The y-axis shows p values from
comparisons. Total binding data only (○) or total binding along with
apparent NSB (●) were fit. Dashed and solid lines connect averages
of log(p) values. At [
3H]EBmax = 100 nM and total binding only, the
CIs included true values (Kd1, 11.9-14.0 pM, mean = 12.9 pM, Kd2,
3.4-12.2 nM, mean = 6.5 nM, R1T, 0.128-0.131 nM, mean = 0.129 nM;
R2T, 0.014-0.021 nM, mean = 0.018 nM) (n = 5 for each CI). With
[
3H]EBmax = 22 nM and explicitly fitting apparent NSB, CIs included
true values (Kd1, 10.6-13.2 pM, mean = 11.8 pM; Kd2, 3.9-17.4 nM,
mean = 8.2 nM; R1T, 0.126-0.131 nM, mean = 0.128 nM; R2T, 0.020-
0.023 nM, mean = 0.021 nM) (n = 5 for each CI). B, C. With zero
NSB and highly precise data (SD = 1 × 10
-4 nM), simultaneously
fitting total binding data and apparent NSB helps identify low-
affinity specific binding. Total binding data in B (40 points) were
generated with R1T = 0.13 nM and [
3H]EBmax = 2.37 nM. The one
site modeltotal and two sites modeltotal appear to fit total binding
data equally well up to [
3H]EBmax. The two sites modeltotal, however,
fits apparent NSB values (●) in C significantly better than does the
one site modeltotal, leading to p =2×1 0
-33 comparing models with
simultaneous fitting. One site modeltotal: Kd = 0.014 nM, RT = 0.13
nM, a = 5.9 × 10
-4; two sites modeltotal: Kd1 = 0.013 nM, Kd2 = 10.5
nM, R1T = 0.013 nM, R2T = 0.022 nM, a = 1.0 × 10
-7.
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Page 8 of 22As a second potential approach, fitting apparent NSB
while simultaneously fitting total binding data might help
distinguish low-affinity specific binding from NSB by
directly evaluating NSB. To test this hypothesis, total
binding data (40 data points) and apparent NSB binding
data (20 data points) were generated with the same con-
ditions (maximum S/N = 1,300; SD = 1 × 10
-4 nM) that
failed to distinguish the low affinity binding site with
total binding data only. Simultaneously fitting total bind-
ing data (Figure 5B) and apparent NSB (Figure 5C) led to
the two sites modeltotal fitting the data significantly better
than the one site modeltotal in five of five data sets. The p
values were vanishingly small (p = 6.5 × 10
-31, 7.3 × 10
-34,
3.2 × 10
-33,1 . 3×1 0
-28, and 2.1 × 10
-33). Figure 5C shows
how fitting apparent NSB led to better detection of low-
affinity specific binding. The one site modeltotal could not
fit total binding and simultaneously accurately fit the
apparent NSB. In contrast, the two sites modeltotal accu-
rately fit the contribution from the low affinity site to
total binding and simultaneously accurately fit the appar-
ent NSB. With more realistic precision (maximum S/N =
36; SD = 0.0041 nM), the two sites modeltotal usually fit
the data better than did the one site modeltotal for [
3H]
EBmax ≥ 22 nM (Figure 5A). In addition, simultaneously
fitting both total binding and apparent NSB data more
reliably identified low-affinity specific binding than did
fitting only total binding. These results suggested that
simultaneously fitting both total binding and apparent
NSB could be superior to fitting only total binding for
detecting low-affinity specific binding when NSB was
negligible.
A third approach for potentially distinguishing low-
affinity specific binding from NSB is based on how NSB
varies with a4b2 nAChR concentration. Suppose, in an
idealized case, that NSB arises solely from sources (e. g.,
walls of a test tube, surface of a glass filter, or a constant
volume of cell membranes) that are independent of
a4b2 nAChR. The independence of NSB from a4b2
nAChR suggests the hypothesis that varying a4b2
nAChR concentration helps distinguish low-affinity spe-
cific binding from NSB when ligand depletion is signifi-
cant. Variation in a4b2 nAChR concentration could
arise by injecting different amounts of cRNA into
oocytes or by transfecting different amounts of cDNA
into cells. To test this hypothesis, the one site modeltotal
and two sites modeltotal with implicit fitting of NSB
were fitted to noisy [
3H]EB binding data (maximum S/N
= 36) generated at three different concentrations of
a4b2 nAChR and with zero NSB (Figure 6A). The two
sites modeltotal consistently fit the data better than the
o n es i t em o d e l total for [
3H]EBmax ≥ 22 nM (Figure 6B).
In contrast, [
3H]EBmax in the range of 100 nM was
needed when the same numbers of data points were
generated under similar conditions from a single a4b2
nAChR concentration (Figure 5A). These results sug-
gested that simultaneous fitting of data from various
a4b2 nAChR concentrations, when NSB is independent
of a4b2 nAChR concentration, could help distinguish
binding to the low affinity binding site better than fitting
data from a single a4b2 nAChR concentration.
Potentially, both sources independent of a4b2 nAChR
concentration and sources correlated with a4b2 nAChR
concentration might contribute significantly to NSB.
The equation describing NSB in this case needs to
include a component independent of (RLNSB, indep)a n d
a component dependent on a4b2 nAChR concentration
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Figure 6 Simultaneously fitting binding data from several
different concentrations of a4b2 nAChR identifies low-affinity
specific binding. A. The one site modeltotal and two sites modeltotal
with [
3H]EBmax = 100 nM were fitted to noisy binding data with R1T
= 0.065, 0.13, and 0.39 nM and a = 0. SD for noise at the R1T
values was 0.002, 0.004, and 0.012, respectively (maximum S/N
ratio≃36). The two sites modeltotal shows a significantly better fit (p
=4×1 0
-7). B. The y-axis shows p values for comparisons of one site
modeltotal and two sites modeltotal from various [
3H]EBmax values.
The fitted data sets are analogous to the data sets shown in A; p-
values from 5 data sets appear at each x-coordinate. Solid lines
connect averages of log(p) values. The CIs of estimates of Kd1 (9.2-
18.5 pM; mean = 13.0 pM) and Kd2 (1.0-1400 nM; mean = 38 nM)
and R2T (0.015-0.66; mean = 0.34) (n = 5 for each CI) include true
values.
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Page 9 of 22(RLNSB, dep). Based on Eqs. (3)-(5) and if RTNSB, dep is
directly proportional to a4b2n A C h R ,t h er e l a t i o n s h i p
between NSB and free ligand becomes:
RLNSB,indep +R L NSB,dep =

RNSB,indep
Kd,NSB,indep
+
RNSB,dep
Kd,NSB,dep

∗ Lf (9)
RLNSB,indep +R L NSB,dep ∼ =

RTNSB,indep
Kd,NSB,indep
+
RTNSB,dep
Kd,NSB,dep

∗ Lf (10)
RLNSB,indep +R L NSB,dep ∼ =

RTNSB,indep
Kd,NSB,indep
+
β ∗ [α4β2]
Kd,NSB,dep

∗ Lf (11)
NSBtotal =R L NSB,indep +R L NSB,dep ∼ =

αind + αdep ∗ [α4β2]

∗ Lf (12)
Eq. (12) for NSBtotal or other expressions for RTNSB,
dep can be incorporated into binding equations (Figure
1) when the low affinity binding site is investigated with
various a4b2 nAChR concentrations and binding
models.
Characterizing the low-affinity specific binding site by
ligand depletion
How does combining NSB with ligand depletion affect
the interpretation of saturation binding with ligand
depletion? Without ligand depletion, large NSB tended
to overwhelm the signal from the low affinity site when
total and free [
3H]EB were high enough to populate the
low affinity binding site (Figure 3A). Conditions leading
to ligand depletion, however, would increase the con-
centration of the low affinity site, reduce free [
3H]EB
and NSB, and lead to relatively more binding to the low
affinity site than to NSB. With a =0 . 1a n dR 1 T=
0.00013 nM (negligible depletion), the ratio R2L/NSB
was 1.1 × 10
-5 at [
3H]EB = 12 nM and 4.4 × 10
-6 at
[
3H]EB = 50 nM. As expected, NSB overwhelmed the
signal from the low affinity site at and above [
3H]EB =
Kd2, which was the minimal concentration range needed
to significantly populate the low affinity site. In contrast,
with R1T = 20 nM (substantial depletion) and the low
affinity site starting to participate in ligand depletion,
the ratio R2L/NSB was much larger: 3.2 at [
3H]EB = 12
nM and 1.0 at [
3H]EB = 50 nM.
To test this promising usefulness for ligand depletion,
noisy data (maximum S/N = 50 at each R1T) with a =
0.1 and significant ligand depletion at three values of
R1T (0.13, 3, and 20 nM; [
3H]EBmax = 0.15, 3.6, and 24
n M )w e r ef i t t e db yt h eo n es i t em o d e l total and the two
sites modeltotal. The two sites modeltotal fit the data bet-
ter in ten of ten trials and produced CIs that included
the true values for the parameters (Kd1 = 0.0133 nM, CI
= 0.0120-0.0149 nM; Kd2 =1 1 . 9n M ,C I=9 . 0 - 1 5 . 8n M ;
fraction of low affinity site = 0.180, CI = 0.156-0.204; a
= 0.098, CI = 0.092-0.103). To test the effect of simulta-
neously fitting apparent NSB, noisy data (maximum S/N
= 50) with a = 0.1 at three values of R1T (0 nM for
apparent NSB alone, 0.13, and 20 nM) were fitted by
the one site modeltotal and the two sites modeltotal.T h e
two sites modeltotal fit the data better in ten of ten trials
and produced CIs including the true values for the para-
meters (Kd1 = 0.0123 nM, CI = 0.0097-0.0156 nM; Kd2 =
31.8 nM, CI = 6.5-155 nM; fraction of low affinity site =
0.291, CI = 0.133-0.450; a = 0.0997, CI = 0.0987-0.101).
These results suggested that increasing ligand depletion
might be useful for detecting and characterizing the low
affinity site when NSB is significant in saturation bind-
ing data.
Effects of ligand depletion and NSB on homologous
competition
To investigate effects of ligand depletion and NSB on
homologous competition, a two sites modelfree and a two
sites modeltotal were developed using concentration of free
or total cold EB as the independent variable (Figure 1B).
Calculations of total binding using the two sites modeltotal
agreed with calculations with two sites modelfree to at least
fourteen significant digits. The ranges of parameters tested
were 1 × 10
-6 nM ≤ R1T ≤ 1×1 0
4 nM and 0 ≤ a ≤ 20
with 1 × 10
-6 nM ≤ [
3H]EBtotal ≤ 1×1 0
6 nM. These results
confirmed the accuracy of modeling homologous competi-
tion using total cold EB concentration as the independent
variable.
Increasing ligand depletion by increasing R1T changed
the appearance of homologous competition data using
0.013 nM [
3H]EB, which equaled the Kd for the high
affinity binding site (Figure 7A). At R1T = 0.00013 nM,
ligand depletion was negligible. The binding curve was
symmetric about IC50 = 0.02612 nM with a Hill coeffi-
cient of -0.9995. The Kd calculated from a modified
Cheng-Prusoff equation for homologous competition
[51], which ignores ligand depletion:
IC50 =[ 3H]EB + Kd (13)
was 0.01316 nM, close to the value of Kd for the high
affinity site. Increasing ligand depletion distorted the
competition curve away from a sigmoidal shape and
shifted the curve rightward. The curve at R1T = 130
nM was asymmetric about IC50 = 306 nM and did not
follow Eq. (13). When [
3H]EB was increased to 13 nM,
[
3H]EB concentration controlled IC50 when ligand
depletion was negligible, agreeing with Eq. (13) (Figure
7B). IC50, therefore, remained about 13 nM for R1T <
13 nM. Increasing ligand depletion shifted IC50 right-
ward when R1T ≥ 13 nM and made the homologous
competition curves asymmetric around IC50.T h e s e
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logous competition data shifted IC50 rightward and
caused asymmetric curves around IC50.
As ligand depletion increased, its effect on binding to
the high affinity site became qualitatively different from its
effect on binding to the low affinity site. With negligible
ligand depletion at R1T = 0.00013 nM and [
3H]EB = 0.013
nM, homologous competition of [
3H]EB binding to the
high and low affinity sites produced similarly shaped sig-
moidal competition curves (Figure 8A and 8B). With sub-
stantial ligand depletion at R1T = 130 nM and [
3H]EB =
0.013 nM, [
3H]EB binding to the high affinity site acquired
a sharp shoulder but continued to decrease monotonically
with increasing cold EB (Figure 8C). At the low affinity
site, substantial ligand depletion produced an asymmetric
peak of [
3H]EB binding (Figure 8D).
Characterizing the low-affinity specific binding site with
homologous competition when NSB is negligible
How well can homologous competition data with ligand
depletion identify the low affinity binding site? Comparing
fits from the one site modeltotal and two sites modeltotal to
n o i s yd a t af r o mas i n g l e[
3H]EB concentration reliably
achieved this goal only with highly precise data (maximum
S/N = 1000) (Figure 9A). With 20 nM [
3H]EB, [
3H]EB
occupied a large fraction (62%) of the low affinity binding
site when cold EB was absent. The result with 20 nM [
3H]
EB and 0.13 nM R1T suggested that occupying both high
and low affinity sites using one high [
3H]EB concentration
was insufficient to identify the low affinity site when S/N
values were realistic. Figure 8C and 8D, however, sug-
gested that combining concentrations of [
3H]EB and bind-
ing sites on the order of Kd2 might lead to a distinctive
concentration dependence of [
3H]EB binding that would
identify the low affinity binding site with less precise data.
Indeed, concentrations of 20 nM [
3H]EB and 20 nM R1T
reliably achieved this goal with less precise data (maxi-
mum S/N = 50) (Figure 9A). These results suggested that
homologous competition data from a single [
3H]EB con-
centration could identify the low affinity binding site with
realistically precise data using large concentrations of [
3H]
EB and a4b2 nAChR binding sites. This approach, how-
ever, consumed large amounts of [
3H]EB and a4b2
nAChR.
Multiple concentrations of [
3H]EB that explored a wide
range of fractional occupancies of the two binding sites
might identify the low affinity binding site while consum-
ing less [
3H]EB and a4b2 nAChR. Improving the interpre-
tation of homologous competition data from two binding
sites by using several concentrations of radioligand has
been described for a general case [7]. To test this method
with [
3H]EB and a4b2 nAChR, homologous competition
data sets from [
3H]EB concentrations of 0.013, 0.3, and 20
nM and R1T = 0.13 nM were generated (Figure 9B-E).
Multiple concentrations of [
3H]EB required less precise
data and consumed less [
3H]EB and a4b2 nAChR to iden-
tify the low affinity site than did a single large [
3H]EB con-
centration (Figure 9A).
Characterizing the low-affinity specific binding site with
homologous competition when NSB is significant
In practice, NSB is not zero and needs to be included in a
model of homologous competition data. NSB, as expected,
moved the baseline above zero at large concentrations of
cold EB. Increasing ligand depletion shifted IC50 rightward
and distorted the monotonically decreasing sigmoidal
shape of the competition curve (Figure 10A). As expected
from modeling of one specific binding site [19], the contri-
bution of NSB to total [
3H]EB binding across the range of
cold EB concentration depended on the extent of ligand
depletion (Figure 10B). The dependence of NSB on ligand
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Figure 7 Ligand depletion affecting homologous competition
data shifts IC50 rightward and distorts the sigmoidal shape of
the competition curve. A. Homologous competition of 0.013 nM
[
3H]EB and a4b2 nAChR at various concentrations of R1T. B.
Homologous competition of 13 nM [
3H]EB and a4b2 nAChR.
Compared with A, the larger [
3H]EB concentration leads to an
initially larger IC50 at small R1T (Eq. (13)) and a larger R1T
concentration needed for the onset of significant ligand depletion.
The curves for the five smallest R1T values overlap and form the
leftmost solid curve. The competition curves of both A and B are
distorted away from sigmoidal shape as ligand depletion increases.
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Figure 8 Homologous competition of [
3H]EB at the low affinity site is substantially different from competition at the high affinity site
when ligand depletion is significant. A and B. Homologous competition from the high affinity site (A) and the low affinity site (B) with [
3H]EB
= 0.013 nM and R1T = 0.00013 nM leads to negligible depletion of [
3H]EB. The competition curves are sigmoidal. C and D.[
3H]EB = 0.013 nM
and R1T = 130 nM lead to significant ligand depletion. Competition at the high affinity site (C) with ligand depletion is a distorted sigmoid
curve similar to the total competition curves at high ligand depletion in Figure 7. In contrast, competition at the low affinity site (D) is a peak
with maximum binding at 190 nM cold EB. From the right-hand scales of A and B with the right-hand scales of C and D, ligand depletion
changes the fractional contribution of the low affinity site to the total binding. The low affinity site contributes less than 3.5 × 10
-4 of the
maximum total binding when ligand depletion is negligible (A and B). In contrast, the low affinity site contributes more than 0.08 of the
maximum total binding with significant ligand depletion (C and D).
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Figure 9 Data exploring a wide range of fractional occupancies of both binding sites help identify the low affinity binding site with
homologous competition data with zero NSB. A. The p-values comparing one site modeltotal and two sites modeltotal depend on the
maximum S/N in the homologous competition data. With R1T = 0.13 nM, single concentrations of [
3H]EB with ([
3H]EB = 0.013 nM; □; average
log(p), short dashed line) or without ([
3H]EB = 20 nM;∇; average log(p), long dashed line) ligand depletion require highly precise data (maximum
S/N > 300) to consistently achieve p < 0.05 (p = 0.05, dotted line). When [
3H]EB and R1T are 20 nM (Δ; average log(p), dash-dot line) and ligand
depletion is significant, less precise data are needed to consistently achieve p < 0.05. With the same number of data points (114 points),
simultaneous fitting of data from concentrations of [
3H]EB at 0.013, 0.3, and 20 nM with R1T = 0.13 nM (●; average log(p), solid line) also needs
less precise data to consistently achieve p < 0.05. Number of trials at each concentration and S/N value was 5. Estimates of dissociation
constants and binding site concentrations are not significantly different from true values when S/N = 50. The CIs of Kd1 (9.6 - 13.8 pM; mean =
11.5 pM) and Kd2 (1.9-22.0 nM; mean = 6.5 nM) and CIs of R1T (0.126-0.131; mean = 0.128) and R2T (0.0198-0.0315; mean = 0.0256) (n = 5 for
each CI) included the true values. B, C, D, and E. The two sites modelfree generated noisy homologous competition data sets with R1T = 0.13
nM; [
3H]EB = 0.013 (●), 0.3 (○), and 20 nM (▼); and maximum S/N = 100 (B), 50 (C), 25 (D), and 15 (E). Fitting the one site modeltotal and two
sites modeltotal to these types of data sets produced p values in A. Lines shown are fits of two sites modeltotal.
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Page 13 of 22depletion showed that simply subtracting the baseline of
bound [
3H]EB at large cold EB concentration from total
bound [
3H]EB did not accurately calculate specifically
bound [
3H]EB. Instead, and similar to saturation binding
with ligand depletion and NSB, interpreting properties of
specific binding of homologous competition data with
NSB needed fitting of total binding.
Homologous competition without NSB suggested
simultaneously fitting data from several [
3H]EB concen-
trations at a constant concentration of a4b2n A C h R
better identified the low affinity site than did fitting data
from a single [
3H]EB concentration (Figure 9A). Apply-
ing this approach at 0.013, 0.3, and 20 nM [
3H]EB to
homologous competition with R1T = 0.13 nM and a =
0.1, however, revealed that NSB overwhelmed specific
binding at 20 nM [
3H]EB. 92% of total [
3H]EB binding
was NSB, 7% was bound to the high affinity site, and
only 1% was bound to the low affinity site in the
absence of cold EB.
As suggested by Figures 8 and 9A, concentrations of
both [
3H]EB and R1T on the order of Kd2 might help iden-
tify binding to the low affinity site. This method populates
the low affinity site relative to the high affinity site and to
NSB (Figure 11A). This method with [
3H]EB and R1T at
20 nM identified binding to the low affinity site with five
of five data sets at S/N = 50 and three of five data sets at
S/N = 25 (Figure 11B). The consumption of a large con-
centration of [
3H]EB and a4b2 nAChR at all data points,
however, was an undesirable outcome.
To reduce [
3H]EB and a4b2 nAChR consumption, both
binding sites and [
3H]EB were varied. This method could
sample a wide range of fractional occupancies of the two
binding sites, which suggested a potential advantage for
interpreting binding to the specific sites (Figure 11A). The
maximum fractional occupancies (R1L/R1T) of the high
affinity site by [
3H]EB were 0.089, 0.29, and 0.97 at [
3]EB =
0.013, 0.3, and 20 nM and at R1T = 0.13, 1, and 20 nM.
For the low affinity site, the maximum fractional occupan-
cies (R2L/R2T) were 0.00081, 0.014, and 0.29. NSB made
a greater fractional contribution to total binding than the
low affinity site for all concentrations of cold EB when
[
3H]EB = 0.013 nM and R1T = 0.13 nM. With [
3H]EB and
R1T at 20 nM, however, [
3H]EB binding by the low affinity
site was greater than NSB up to 24 nM cold EB (Figure
11A). These results suggest e dt h i sm e t h o dm i g h ta d e -
quately sample the contribution by the low affinity site to
total binding during fitting of noisy data when NSB was
significant.
The method was tested by comparing one site model-
total and two sites modeltotal fits to noisy data from three
pairs of [
3H]EB concentrations and binding site concen-
trations. The low affinity site was identified with five of
five data sets with S/N = 50 and four of five data sets
with S/N = 25 (Figure 11B). These results suggested
that simultaneous fitting of homologous competition
data from several concentrations of [
3H]EB and binding
sites has the potential to identify low-affinity specific
binding in the presence of NSB.
Potential misinterpretation of low-affinity specific binding
as NSB in homologous competition binding
Even with highly precise data, Eqs. (3) to (5) suggested a
possibility of misinterpreting low-affinity specific binding
as NSB in homologous competition data when only fit-
ting total binding data. A low affinity, second specific
binding site with a large relative concentration could
mimic NSB as long as R2≈R2T over the range of cold
EB concentration. Although a large relative concentra-
tion of the second binding site was not observed from
expression of a4b2 nAChR in oocytes [18], such a con-
dition potentially could arise in a different heterologous
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Figure 10 The contribution of NSB to total binding of
homologous competition data depends on the concentration
of cold EB when ligand depletion is significant. A. The presence
of NSB (a = 0.1, [
3H]EB = 0.013 nM) displaces the baseline of bound
[
3H]EB above the x-axis. Ligand depletion does not affect the size of
this signal at large concentrations of cold EB, which in this case is
equivalent to the apparent NSB. As anticipated from Figure 7,
increasing ligand depletion in the presence of NSB shifts IC50
rightward and distorts the sigmoidal shape of the competition
curve. R1T values increase in one log unit increments. B. NSB is not
constant along the x-axis. Increasing ligand depletion with
increasing R1T reveals the sigmoidal or distorted sigmoidal
appearance of NSB as a function of cold EB and shifts the NSB
curve rightward. Conditions and legend are the same as in A.
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Page 14 of 22expression system. The potential for confusing low-affi-
nity specific binding and NSB was explored by compar-
ing homologous competition data from a one site
modelfree with a = 0.2 with data from a two sites model-
free with a =0a n dKd2 =R 2 T / 0 . 2 .A sR 2 Ta n dKd2
increased, the upper limit of cold EB concentration for
which R2 R2T remained valid also increased. The data
from the two sites modelfree with zero NSB, therefore,
displayed increasingly long plateaus mimicking NSB at
large concentrations of cold EB. The long plateaus, how-
ever, arose from specific binding to the low affinity
a4b2 nAChR binding site and not from NSB. Figure
12A suggested that homologous competition data at a
single [
3H]EB concentration might not distinguish bind-
ing to a low affinity site from NSB unless either the
maximum concentration of cold EB exceeded Kd2 or
NSB was measured without a4b2 nAChR.
Heterologous competition with ligand depletion and NSB
Homologous competition is a specific case of the more
general case of heterologous competition, for which the
dissociation constants of the radioligand and the hetero-
logous competitor differ. For heterologous competition,
identification of a low affinity site and estimates for dis-
sociation constants for [
3H]EB to high and low affinity
sites typically are determined from saturation binding.
In this case, inhibition constants (Ki1 and Ki2 in Figure
1) for the competitor and the concentration of binding
sites are the only unknowns when fitting heterologous
displacement data. This study focuses on how ligand
depletion and NSB affects heterologous competition
with high and low affinity binding sites of [
3H]EB. In
addition, this study investigates concentrations of [
3H]
EB and a4b2 nAChR that might facilitate studying the
low affinity site.
To determine how ligand depletion without NSB
affects heterologous competition with [
3H]EB and a4b2
nAChR, competition data at increasing concentrations
of binding sites were generated with nicotine as the
competitor. The dissociation constants for nicotine were
0.84 nM for the high affinity site [18] and 775 nM for
the low affinity site. The inhibition constant for nicotine
at the low affinity site was assigned so that Ki2/Ki1 for
nicotine = Kd2/Kd1 for EB. When ligand depletion was
negligible, IC50 values varied only slightly with binding
site concentration (Figure 13A-F). The Ki values derived
from these IC50 values and the Cheng-Prusoff equation
(Eq. (14)),
IC50 =[ 3H]epibatidine + Ki (14)
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Figure 11 Ligand depletion helps identify the low affinity site
when NSB is significant in competition data. A. Increasing
concentrations of binding sites and [
3H]EB samples a wide range of
fractional contributions of the two binding sites and NSB to total
binding. The combination [
3H]EB = 0.013 nM and R1T = 0.13 nM
mostly samples behavior of the high affinity site. The low affinity
site contributes at most one-hundredth of the total binding; its
contribution is always smaller than NSB. In contrast, the
combination [
3H]EB = 20 nM and R1T = 20 nM more effectively
samples behavior of the low affinity site. The low affinity site
contributes a maximum of one-tenth of the total binding and
contributes more than NSB does to total binding up to about 20
nM cold EB. The y-axis values are calculated as Q/(R1L+R2L+NSB)
where Q = R1L, R2L, or NSB. These results suggest this approach
might adequately sample the contribution from the low affinity site
to total binding during fitting of noisy data. B. The p values
compare fits from one site modeltotal and two sites modeltotal to
competition data generated with a = 0.1. One set (Δ) used [
3H]EB =
R1T = 20 nM; the second set (□), [
3H]EB = 0.013, 0.3, and 20 nM and
R1T = 0.13, 1, and 20 nM. Lines show average log(p). At S/N = 50
for the first set, CIs included the true values (Kd1 = 0.016 nM (CI:
0.010-0.025 nM); Kd2 = 14.9 nM (CI: 6.3-35 nM); R1T = 20.2 nM (CI:
19.7-20.6 nM); R2T = 4.7 nM (CI: 2.8-6.6 nM); a = 0.096 (CI: 0.091-
0.100) (n = 5 for each CI). At S/N = 25 for the second set, CIs
included the true values (Kd1 = 0.012 nM (CI: 0.009-0.014 nM); Kd2 =
17.0 nM (CI: 4.3-66 nM); fraction of R2T = 0.28 (CI: 0.11-0.45); a =
0.10 (CI: 0.093-0.108).
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Page 15 of 22which assumes a single binding site without ligand
depletion, were close to Ki1 for nicotine (0.90, 0.87, and
0.96 nM at 0.013, 0.3, and 20 nM [
3H]EB and R1T =
0.00013 nM). As increasing ligand depletion shifted IC50
rightward (Figure 13A-F), the estimate of Ki from the
Cheng-Prusoff equation no longer closely matched Ki1
for nicotine. The shape of the competition curve
remained approximately sigmoidal with a Hill coefficient
consistently near -1 at all levels of ligand depletion.
Although nicotine binds more weakly than [
3H]EB to
a4b2 nAChR, other ligands developed in the future,
especially derivatives of EB, conceivably might bind
more tightly than [
3H]EB. To determine how ligand
depletion affects heterologous competition with a super-
high affinity competitor, heterologous competition data
were generated with two dissociation constants 100-fold
tighter (1.3 × 10
-4 and 0.12 nM) than the two dissocia-
tion constants for [
3H]EB. When ligand depletion of
[
3H]EB was negligible, IC50 values were independent of
binding site concentration and led to slightly high esti-
mates of Ki1 (1.4 × 10
-4 nM) using Eq. (14); Hill coeffi-
cients were about -1 (Figure 13G-L). Increasing ligand
depletion shifted IC50 rightward and, in contrast to
nicotine, shifted Hill coefficients to strongly negative
values (for example, -35 with [
3H]EB = 0.013 nM and
R1T = 130 nM). These results showed the effect of
ligand depletion on the Hill coefficient depended mark-
edly on whether the competitor bound more tightly or
less tightly than [
3H]EB.
Ki2 for a competitor potentially can be estimated with
procedures analogous to procedures investigated for
homologous competition. To test the approach described
in Figures 9 and 11 for homologous competition, noisy
heterologous competition data for nicotine and [
3H]EB
with ligand depletion and NSB were fit with the two
sitestotal model (Figure 14). A single 0.013 nM concentra-
tion of [
3H]EB with R1T = 0.13 nM did not significantly
populate the low affinity site (Figure 14A). That concen-
tration combination produced reliable estimates of Ki2
only with highly precise data (maximum S/N ≥ 1000)
(Figure 14C). At maximum S/N = 100, fits with competi-
tion by nicotine at the high and low affinity sites gener-
ally were not significantly better than fits with
competition by nicotine at only the high affinity site (p >
0.05 for six of six trials). Similar to the findings in Figures
9 and 11, increasing ligand depletion and populating
both the high and low affinity sites with larger concentra-
tions of [
3H]EB and a4b2 nAChR (Figure 14B) allowed
more reliable estimates of Ki2 with less precise data (Fig-
ure 14C). At maximum S/N = 15 with this approach, fits
with competition by nicotine at the two [
3H]EB binding
sites generally were significantly better than fits with
competition by nicotine at only the high affinity site
(0.007 <p <5×1 0
-10 for six of six trials). These results
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Figure 12 Binding to a low affinity second binding site with
hypothetically large R2T and Kd2 or Ki2 values mimic NSB in
homologous and heterologous competition data. A. The one
site modelfree (a = 0.2) and two sites modelfree (a = 0) generated
homologous competition data with Kd2 = R2T/0.2. With increasing
R2T and Kd2, the two sites modelfree produces increasingly long
plateaus of total bound [
3H]EB, similar to NSB. Low-affinity specific
binding is distinguished from NSB only when cold EB concentration
exceeds Kd2. B. Heterologous competition of [
3H]EB with a nicotine-
like competitor at a low affinity site can mimic NSB. The one site
modelfree with a = 0.2 generated heterologous competition data
with Ki1 = 0.84 nM for the competitor (value for nicotine [18]). With
these values and R2T = 2.4 nM and a = 0, the two sites modeltotal
fits these data well up to a competitor concentration of Ki2. Low-
affinity specific binding is distinguished from NSB only when the
competitor concentration exceeds Ki2. C. With a superhigh affinity
competitor, increasing R2T and varying Ki2 with heterologous
competition of [
3H]EB at a low affinity site can mimic NSB. The one
site modelfree with a = 0.2 generated heterologous competition
data with Ki1 = 1.3 × 10
-4 nM. With a = 0, the two sites modeltotal
fits well to these data up to a competitor concentration of Ki2. Low-
affinity specific binding is distinguished from NSB only when
competitor concentration exceeds Ki2.
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Figure 13 Effects of ligand depletion on heterologous competition data depend on the relative affinity of the inhibitor. A-F.
Competition data for [
3H]EB and nicotine were generated with two sites modelfree with [
3H]EB = 0.013 (A & B), 0.3 (C & D), and 20 nM (E & F)
and the R1T values shown in C. The y-axes of A, C, and E show total bound [
3H]EB; y-axes of B, D, and F show normalized binding for
comparing IC50 values. Data from small values of R1T are not distinguishable because of the ranges of the y-axis scales (A, C, and E) or because
data sets overlap when rightward shifts of IC50 are negligible (B, D, and F). Ligand depletion shifts IC50 rightward; shape of the competition curve
remains approximately sigmoidal. G-L. Competition data for [
3H]EB and a hypothetical superhigh affinity competitor were generated with two
sites modelfree with [
3H]EB = 0.013 (G & H), 0.3 (I & J), and 20 nM (K & L) and the R1T values shown in L. The two inhibition constants Ki1 and Ki2
were 100-fold tighter (1.3 × 10
-4 and 0.12 nM) than Kd1 and Kd2 for [
3H]EB. Ligand depletion shifts IC50 rightward and increases the maximum
steepness of the negative slope of the sigmoidal shape. Hill coefficients at R1T = 130 nM are -35, -35, and -17 for [
3H]EB = 0.013, 0.3, and 20 nM.
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Page 17 of 22suggest that fitting data with large ligand depletion might
identify the presence of nicotine competition at the low
affinity site even if those data have a low S/N and an esti-
mate of Ki2 has low precision.
Similar to homologous competition data (Figure 12A),
low-affinity specific binding might be misinterpreted as
NSB when fitting heterologous competition data with a
model of total binding. To investigate this possibility with
a nicotine-like inhibitor (Ki1 = 0.84 nM), heterologous
depletion data from the one site modelfree with NSB (a =
0.2) were compared to data from the two sites modeltotal
without NSB. With R2T = 2.4 nM and various values of
Ki2,t h et w os i t e sm o d e l total produced a long plateau
mimicking NSB (Figure 12B). The value of Ki2 at this con-
stant value of R2T determined the length of the plateau
along the x-axis. One log unit increase of the value of Ki2
lengthened the plateau of binding to the low affinity site
by one log unit. A competitor binding more tightly than
[
3H]EB to the high affinity binding site produced similar
results (Figure 12C). These results suggested that binding
to the low affinity site might be identified as NSB at a sin-
gle [
3H]EB concentration unless either the maximum
competitor concentration was greater than Ki2 or NSB was
measured without a4b2 nAChR.
Characterizing high and low affinity binding sites when
NSB of a heterologous competitor is unknown
The NSB of an unlabeled competitor is not measured by
heterologous competition measurements and often is
assumed to be zero. The true value of acompetitor, therefore,
presents a source of uncertainty about values of inhibition
constants. This uncertainty was investigated by increasing
values of acompetitor while nicotine (Figure 15A) or a super-
high affinity competitor (Figure 15C) inhibited binding of
[
3H]EB to a4b2 nAChR. As the true value of acompetitor for
nicotine increased, apparent values of Ki1 (Ki1, app)a n dKi2
(Ki2, app) also increased (Figure 15B). The contours of
competition curves with the superhigh affinity competitor
changed as acompetitor increased (Figure 15C), in contrast
to the constant contours with nicotine. The ratio Ki2, app/
Ki1, app for the superhigh affinity competitor, however, was
invariant as acompetitor increased (Figure 15D). The invar-
iance of Ki2, app/Ki1, app at the two binding sites of a4b2
nAChR is important because the ratio represents the dif-
ference in free energy of binding at the two binding sites.
This difference reflects differences in the interactions
between the competitor and binding sites and structural
differences between the high and low affinity binding sites.
This measured free energy difference is independent of
acompetitor.
Discussion
A model that fits total binding data as a function of
total ligand can correctly interpret those data when
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Figure 14 Ligand depletion improves precision of estimated
Ki2 for nicotine with noisy data and NSB. Ligand depletion
improves precision of estimated Ki2 for nicotine with noisy data. A
and B. Increasing concentrations of binding sites and [
3H]EB
samples a wide range of fractional contributions of the two binding
sites and NSB to total [
3H]EB binding as nicotine concentration
varies. In A, the combination [
3H]EB = 0.013 nM and R1T = 0.13 nM
predominantly samples interaction between [
3H]EB and nicotine at
the high affinity site. In B, the combination [
3H]EB = 20 nM and R1T
= 20 nM with substantial ligand depletion more effectively samples
interaction between [
3H]EB and nicotine at the low affinity site. The
low affinity site contributes a maximum of one-tenth of total [
3H]EB
binding and contributes more than NSB does to total [
3H]EB
binding up to about 1000 nM nicotine. The y-axis values were
calculated as Q/(R1L+R2L+NSB) where Q = R1L, R2L, or NSB. C.
Noisy heterologous competition data for [
3H]EB and nicotine with
various maximum S/N were fit with two sitestotal model to estimate
Ki1 and Ki2. The Ki2 estimates shown with green Δ were derived with
R1T = 0.13 nM. Modest ligand depletion and negligible occupancy
by [
3H]EB of the low affinity binding site lead to low precision of Ki2
estimates at maximum S/N = 300. Ki2 estimates shown with blue ▲
were derived with R1T = 0.13, 1, 20 nM. Increasing ligand depletion
and occupancy of the low affinity site by [
3H]EB lead to more
precise Ki2 estimates with noisier data. Error bars show standard
deviations. Ki1 estimates (green ○ or blue ●) are relatively
independent of maximum S/N values. The number of data points
(114 points) was identical in the two sets of estimates. Solid line:
true Ki1 (0.84 nM); dashed line: true Ki2 (775 nM); aL = 0.1; aB =0 .
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Page 18 of 22ligand depletion and NSB are significant [19]. This
approach is straightforward with one binding site. This
study shows that the approach for [
3H]EB, a4b2
nAChR, and two binding sites needs modifications for
identifying binding to the low affinity site. In particular,
identifying the low affinity site can be challenging
because of phenomenological and computational simila-
rities between low-affinity specific binding and NSB.
This study is novel because it shows that fitting total
binding data from [
3H]EB and a4b2n A C h Rm i g h tb e
insufficient for characterizing the low affinity site when
ligand depletion and NSB are significant. Moreover, this
investigation develops four concepts for studying the
low affinity binding site of a4b2 nAChR in the presence
of ligand depletion and NSB that go beyond simply fit-
ting total binding. First, binding of [
3H]EB to the low
affinity site in saturation data or homologous competi-
tion data can be misattributed to NSB. Low-affinity spe-
cific binding can be identified by using larger maximum
concentrations of [
3H]EB or cold competitor, simulta-
neously fitting apparent NSB, or obtaining data from
multiple concentrations of a4b2 nAChR. Potential
ambiguity between low-affinity specific binding and NSB
arises because they share a similar appearance as long as
R2≃R2T. Increasing [
3H]EBmax for saturation binding or
increasing the maximum concentration of cold competi-
tor for competition binding breaks this similarity by
creating conditions for which R2≪R2T, R2L≃R2T, and
R2B≃R2T.
Second, when NSB is significant, ligand depletion can
help characterize the low affinity site. Ligand depletion
in binding studies is commonly believed to be only pro-
blematic. In contrast, increasing ligand depletion by
increasing a4b2 nAChR concentration beneficially
reduced NSB and significantly populated the low affinity
site. The result was better detection of [
3H]EB binding
to the low affinity site.
Third, directly measuring NSB without a4b2n A C h R
can more reliably interpret NSB than does modeling
NSB as a component of total binding in competition
binding. Whether [
3H]EB binding at a particular large
concentration of competitor arises solely from NSB
depends on Ki2 and concentration of the low affinity
site. Removing a4b2 nAChR from the assay, when feasi-
ble, is a more rigorous way than is using a large concen-
tration of competitor to ensure that [
3H]EB binding
arises from NSB and does not involve the low affinity
site of a4b2 nAChR.
Fourth, acompetitor needs to be considered when inter-
preting heterologous competition data with [
3H]EB and
a4b2 nAChR because it increases Ki1, app and Ki2, app.
T h et r u ev a l u e so fKi1 and Ki2, therefore, can be deter-
mined only when acompetitor is known. Regardless of
acompetitor,h o w e v e r ,Ki2, app/Ki1, app is invariant and
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Figure 15 NSB of a competitor changes Ki1, app and Ki2, app but
not Ki2, app/Ki1, app. A. The two sites modelfree generated
competition data for [
3H]EB and nicotine with R1T = 0.013 nM and
R2T = 3.9 nM so the competition curve clearly shows the two
binding sites. Increasing acompetitor shifted the curve rightward
without changing the shape of the curve. B. To determine how
increasing acompetitor affected apparent values of Ki1 (Ki1, app) and Ki2
(Ki2, app) with acompetitor, app = 0, two sites modeltotal was fitted to
the competition curves in A. The only degrees of freedom for this
fitting were Ki1, app and Ki2, app for nicotine. Increasing acompetitor
increases Ki1, app and Ki2, app but does not change Ki2, app/Ki1, app,a
ratio reflecting the difference in free energy of nicotine binding at
the two sites. C. Similar to A, the two sites modelfree generated
competition data for [
3H]EB and a superhigh affinity competitor
with R1T = 0.013 nM, R2T = 3.9 nM, Ki1 = 0.00013 nM, and Ki2 =
0.12 nM. The curves clearly show the two binding sites. In contrast
to A, shapes of the competition curves change as increasing
acompetitor shifts the curve rightward. D. Similar to nicotine, Ki2, app/
Ki1, app for the superhigh affinity competitor does not vary with
acompetitor.
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Page 19 of 22equals Ki2/Ki1. This ratio can help compare structural
features of the two binding sites of a4b2 nAChR. For
example, variations in the ratio for a series of competi-
tors with systematic structural variations might correlate
with structural features of the two binding sites.
The findings presented in this study have limitations.
First, modeling explored conditions suitable for charac-
terizing low affinity binding that might not match con-
ditions readily available in a laboratory. One such
condition is nanomolar concentrations of a4b2 nAChR.
This high range of a4b2 nAChR concentration might be
more available in the future with high level heterologous
expression of a4b2 nAChR. Quantitative results, such as
concentration ranges that identify the low affinity site,
are a reasonable but not definitive guide to conditions
for studying the low affinity site of a4b2n A C h Rw i t h
[
3H]EB. For example, values of a might be substantially
smaller than the values illustrating NSB in this study.
With membrane homogenates from stably transfected
HEK 293 cells, a was on the order of 0.001 [52]. In
addition, changes in the fraction of low affinity site, as
might occur with different expression conditions, will
change the appearance of data. A larger fraction of low
affinity site would make detection and analysis of this
site easier. Second, the simulations included large num-
bers of data points with the goal of reliably describing
binding data. Fewer data points would need higher pre-
c i s i o ni nt h ed a t at oi d e n t i f y the low affinity site and
would lead to reduced precision of binding parameter
estimates. Third, the properties of noise imposed on
errorless data in this study do not necessarily reflect
properties of real noise and uncertainties in experi-
ments. Fourth, based on binding data from our labora-
tory [18], this study assumes two independent binding
sites in a4b2 nAChR. Other descriptions of binding
sites (for example, two cooperative binding sites, a com-
bination of cooperative and independent binding sites,
or more than two independent sites) might better
describe binding data from a4b2 nAChR under other
conditions. Fifth, the linear relationship between free
[
3H]EB and NSB led to the phenomenological and com-
putational similarity between low affinity binding and
NSB expressed in Eqs. (3)-(5). This linear relationship
usually describes the behavior of NSB. This linear rela-
tionship might be unsuitable for some situations. For
example, if NSB in the absence of specific binding is
observed to be saturable [53-55], the linear relationship
would need to be modified. Sixth, statistical compari-
sons using the F-test and p values between the one site
modeltotal and two sites modeltotal were suitable because
of the nested nature of the two models. In other words,
the two sites modeltotal contained all the features of the
o n es i t em o d e l total and extended those features by a
second specific binding site. Other statistical methods
for comparing models do not need nested models, such
as Akaike’s information criterion [7,56,57]. Seventh, the
independent variable for the models in this study is the
concentration of total ligand ([
3H]EB for saturation
binding or a cold ligand for competition). This variable
usually is accurately known and was presumed to be
free of uncertainty. Using the measured concentration
of free ligand as the independent variable simplifies the
model equations. The measured free ligand concentra-
tions, however, will have nonnegligible uncertainty. The
method of least squares might not reliably estimate
parameter values when the values of the independent
variable are uncertain [1,2,58].
Conclusions
Characterizing the low affinity site potentially will con-
tribute understanding of structure, function, and synth-
esis of a4b2 nAChR in native and heterologous
expression systems. For example, the low affinity site
might arise from an immature form of a4b2n A C h Ro r
be involved in ligand-induced upregulation [32,59-61].
Heterologous competition data similar to Figure 12B
were found with cytisine, nicotine, and acetylcholine as
competitors of [
3H]EB binding with a4b2n A C h R
immunoisolated with monoclonal antibody (mAb) 295
but not with other mAbs [18]. This similarity suggests
that mAb 295 might isolate a distinctive form of low
affinity a4b2 nAChR. Homologous competition data
might help further characterize this form of a4b2
nAChR. An intriguing possibility is that this low affinity
form contributes to the biological roles of a4b2 nAChR.
This study should help investigators design experiments
and develop computational approaches for interpreting
data from [
3H]EB and a4b2 nAChR when ligand deple-
tion and NSB are significant. Manipulation of maximum
ligand and receptor concentrations and intentionally
increasing ligand depletion are potentially helpful
approaches. Extending the modeling and numerical
solution method to three or more binding sites and to
cooperative binding with ligand depletion and NSB is
straightforward. Although applied specifically to [
3H]EB
and a4b2 nAChR, the methods should be relevant to
other contexts of multiple binding sites, ligand deple-
tion, and NSB.
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